544611 MAHALIFE

Mahamaya Lifesciences Share Price

 

 

Start SIP in MAHALIFE

Start SIP

Mahamaya Lifesciences Performance

  • Low
  • ₹164
  • High
  • ₹164
  • 52 Week Low
  • ₹111
  • 52 Week High
  • ₹205
  • Open Price₹164
  • Previous Close₹156
  • Volume2,400
  • 50 DMA₹170.10
  • 100 DMA-
  • 200 DMA-

Investment Returns

  • Over 1 Month -2.5%
  • Over 3 Month + 41.5%

Smart Investing Starts Here Start SIP with Mahamaya Lifesciences for Steady Growth!

Invest Now

Mahamaya Lifesciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 29.6
  • PEG Ratio
  • -
  • Market Cap Cr
  • 383
  • P/B Ratio
  • 6
  • Average True Range
  • 8.68
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • 0.12
  • RSI
  • 41.86
  • MFI
  • 53.07

Mahamaya Lifesciences Financials

Mahamaya Lifesciences Technicals

EMA & SMA

Current Price
₹163.50
+ 7.45 (4.77%)
pointer
  • Bearish Moving Average 10
  • Bullish Moving Average 1
  • 20 Day
  • ₹174.58
  • 50 Day
  • ₹170.10
  • 100 Day
  • -
  • 200 Day
  • -

Resistance and Support

163.5 Pivot Speed
  • R3 163.50
  • R2 163.50
  • R1 163.50
  • S1 163.50
  • S2 163.50
  • S3 163.50

Mahamaya Lifesciences Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-12-02 Half Yearly Results

Mahamaya Lifesciences F&O

Mahamaya Lifesciences Shareholding Pattern

56.35%
0.95%
6.39%
12.72%
23.59%

About Mahamaya Lifesciences

  • NSE Symbol
  • MAHALIFE
  • BSE Symbol
  • 544611
  • Managing Director
  • Mr. Krishnamurthy Ganesan
  • ISIN
  • INE0U9D01019

Similar Stocks to Mahamaya Lifesciences

Mahamaya Lifesciences FAQs

Mahamaya Lifesciences share price is ₹163 As on 03 March, 2026 | 01:20

The Market Cap of Mahamaya Lifesciences is ₹382.7 Cr As on 03 March, 2026 | 01:20

The P/E ratio of Mahamaya Lifesciences is 29.6 As on 03 March, 2026 | 01:20

The PB ratio of Mahamaya Lifesciences is 6 As on 03 March, 2026 | 01:20

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23